Compositions and methods for reducing the risk of preterm labor
AssigneeNora Therapeutics, Inc.
InventorDarryl Carter
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions, kits and methods for the prevention of spontaneous abortion or implantation failure during assisted reproduction. The compositions, kits and methods provide an effective amount of granulocyte colony stimulating factor to prevent spontaneous abortion or implantation failure of an embryo. The present invention also provides compositions, kits and methods for the treatment or prevention of preeclampsia and preterm labor.
Claims29
-26. (canceled)
A method for reducing the risk of preterm labor, comprising administering to a human female an effective amount of a granulocyte colony stimulating factor (G-CSF), wherein the G-CSF is administered at a dose ranging from 1 to 100 mcg (micrograms)/kg/day.
A kit for preventing or reducing the risk of preterm labor in a human female, comprising an effective amount of G-CSF;
- and a label with instructions for using G-CSF at a dose ranging from 1 to 100 mcg (micrograms)/kg/day to prevent or reduce the risk of preterm labor.
Dependencies are inferred from the claim text.